News:
European markets close higher ahead of Christmas shutdown; Novo Nordisk resumes recovery - Stocks making the biggest moves premarket: Novo Nordisk, Honda, Xerox, Tesla and more - Stocks making the biggest moves midday: Novo Nordisk, Mission Produce, Occidental Petroleum and more - Novo Nordisk shares tumble as data on weight-loss drug trial disappoints - Novo Nordisk: Shares Look Fairly Valued After CagriSema Disappointment - Clone - Stocks making the biggest moves premarket: Novo Nordisk, FedEx, Nike, Starbucks, MicroStrategy and more - Novo Nordisk shares plunge on the back of disappointing trial results - Novo Nordisk shares plunge 20% after disappointing trial results; Lilly jumps - Ozempic Maker Novo Nordisk's Plunge Echoes Nokia Risk - Healthy Returns: A huge deal to boost Novo Nordisk's manufacturing is one step closer to closing
Novo Nordisk
Key facts
- country: Germany
- sector: Health Care
- industry: Pharmaceuticals
Classified as: organization
Summary
Novo Nordisk is a company. It is located in Germany. The company is part of the Health Care sector, specifically in the Pharmaceuticals industry.
Business
Novo Nordisk is one of the companies in Germany, companies in Pharmaceuticals, companies in Health Care and 3,466,499 companies in our database.
Stocks from Novo Nordisk
Explore more on business
Talking Points:
- Novo Nordisk Pharma GmbH
- Novo Nordisk ist ein weltweit führendes Unternehmen im Gesundheitswesen, das 1923 gegründet wurde und seinen Hauptsitz außerhalb von Kopenhagen, Dänemark, hat. Wir treiben Veränderungen voran mit dem Ziel, Diabetes und andere schwerwiegende chronische Krankheiten wie Adipositas und seltene Blut- und Stoffwechselkrankheiten zu besiegen.
- Daily news about diabetes, obesity and other serious chronic diseases. We're global, but here in person for your questions and comments 💬 Community guide 👇
- Driving change to defeat diabetes and other serious chronic diseases. Join us to learn more about our latest innovations | Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity and rare blood and ...
Learn more about talking points